Clinical Trial Update: Efficacy of a Minimally Invasive Therapy Adjuvant to the Standards of Care by Cyanoacrylate Embolization [NA]

View source ↗

Summary

A clinical trial in Brest is evaluating cyanoacrylate embolization as a minimally invasive adjuvant therapy for chronic subdural hematoma; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• Cyanoacrylate embolization (n-butyl cyanoacrylate)

Snippet

Sponsor: University Hospital, Brest | Conditions: Chronic Subdural Hematoma | NA | Status: RECRUITING